Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Planned Departure Of FDA Principal Deputy Commissioner Could Leave Leadership Vacuum

Dec 18 2024

• By Sue Sutter

Office chairs above word "Vacancy" — (Rawpixel.com/Shutterstock)

Related Content

US FDA Commissioner Nominee Not ‘Pro-Industry Choice,’ GLP-1 Compounding Could Be First Clash

Nov 26 2024

US FDA Might Be Temporarily Headed By Ostroff As Califf Sets His Departure

Jan 05 2017

Gottlieb Becomes US FDA Commissioner With Immediate Issues Pending

May 10 2017

US FDA Faces Succession Questions As Hahn’s Departure Nears

Jan 06 2021

As New Tech Emerges For Early Research, FDA Chief Scientist Says Diversity Must Start In Preclinical Development

Sep 21 2023

US FDA Chief Scientist Thinks Increased Data Literacy Can Counter Misinformation

Aug 08 2023

Makena Enforcement Discretion, Compounding Still In Limbo Post Long-Awaited Withdrawal

Apr 06 2023

US FDA Chief Scientist Bumpus Will Become Principal Deputy Commissioner

Nov 29 2023

US FDA’s Office Of Regulatory Affairs To Focus On Investigations, Inspections And Imports

Jul 12 2023

Intarcia’s Exenatide Implant Rejected Again As US FDA Denies Comparative Safety Argument

Aug 23 2024

US FDA’s Drug Center Losing Shortages, Controlled Substance Leadership With Throckmorton Retirement

Nov 21 2024

FDA Cosmetics Director Katz Retires After 22 Years; Manga To Lead OCAC On Acting Basis

Dec 09 2024

Related Companies

Covis Pharma B.V.

Intarcia Therapeutics, Inc.

Additional Topics

FDA Elections Leadership

More from Medtech Insight

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window